The global market for healthcare
nanotechnology is expected to reach USD 196.02 billion by 2020 growing
at a CAGR of 12.1%, according to a new study by Grand View Research,
Inc. Increasing susceptibility of patients towards chronic diseases such
as cardiovascular, neurological, oncology and respiratory diseases
coupled with increasing R&D spending opening new application avenues
is expected to drive market growth over the next six years. Other
drivers of this market include increasing government and private sector
R&D aid and new players entering the market to bridge the gap
between supply and demand.
Clinical oncology nanotechnology
applications dominated the overall market in 2013, accounting for 35% of
total market revenue. Higher efficacy of nanomaterials and the ability
of engineered nanoparticles to cross through the blood brain barrier
provides platform for groundbreaking innovations through R&D in the
field of cancer therapy and serves this market as a high impact
rendering driver.
The report “Healthcare Nanotechnology
(Nanomedicine) Market Analysis By Application (Drug Delivery System,
Molecular Diagnostics, Clinical Oncology, Clinical Neurology, Clinical
cardiology, Anti-inflammatory, Anti-infective) And Segment Forecasts To
2020,” is available now to Grand View Researchcustomers and can also be
purchased directly at http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology
Further key findings from the study suggest:
• North America was the largest regional
market in 2013, accounting for over 38% of global revenue on account of
the extensive investments in research and development of innovative
cancer therapies.
• Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
• Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
• Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
• Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
For the purpose of this study, Grand
View Research has segmented the global healthcare nanotechnology market
on the basis of fields of application and region:
• Healthcare Nanotechnology Application Outlook
• Drug delivery Systems
• Molecular Diagnostics
• Clinical Oncology
• Clinical Neurology
• Clinical Cardiology
• Anti-inflammatory and Anti-infective applications
• Healthcare Nanotechnology Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW
About Grand View Research
• Drug delivery Systems
• Molecular Diagnostics
• Clinical Oncology
• Clinical Neurology
• Clinical Cardiology
• Anti-inflammatory and Anti-infective applications
• Healthcare Nanotechnology Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW
About Grand View Research
Grand View Research, Inc. is a market
research and consulting company that provides off-the-shelf, customized
research reports and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from
technology to chemicals, materials and energy. With a deep-seated
understanding of varied business environments, Grand View Research
provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com
No comments:
Post a Comment